MARIA JESUS SANZ FERRANDO-rekin lankidetzan egindako argitalpenak (14)

2023

  1. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction

    Frontiers in Endocrinology, Vol. 14

2021

  1. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects

    International Journal of Clinical Practice, Vol. 75, Núm. 4

2019

  1. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  2. Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: Changes in cytokine/chemokine profile, increased platelet and leukocyte activation

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  3. SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Núm. 8, pp. 1614-1628

2016

  1. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/lymphotoxin β-receptor pathway

    Thrombosis and Haemostasis, Vol. 116, Núm. 2, pp. 379-393

  2. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 36, Núm. 8, pp. 1587-1597

2015

  1. Combined Sub-Optimal Doses of Rosuvastatin and Bexarotene Impair Angiotensin II-Induced Arterial Mononuclear Cell Adhesion Through Inhibition of Nox5 Signaling Pathways and Increased RXR/PPARα and RXR/PPARγ Interactions

    Antioxidants and Redox Signaling, Vol. 22, Núm. 11, pp. 901-920

  2. Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE-/- mice and angiogenesis

    British Journal of Pharmacology, Vol. 172, Núm. 12, pp. 2946-2960

  3. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis

    Journal of Endocrinology, Vol. 227, Núm. 3, pp. 179-191

  4. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 9, pp. 1729-1742

2014

  1. Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis

    Cardiovascular Research, Vol. 103, Núm. 2, pp. 324-336

2013

  1. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-ii

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 1, pp. 96-104

  2. Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging

    Aging Cell, Vol. 12, Núm. 1, pp. 102-111